A coalition of patient organisations has challenged an unpublicised move to restrict CBD and label it as a precursor to other drugs, warning that consumers could be pushed into unregulated markets if a ban is put in place.
When Jeremy Berke left Business Insider at the end of 2022, he didn’t necessarily intend on launching his own media... read more
The Caribbean country has passed legislation allowing possession and cultivation of small amounts of cannabis for adults over the age... read more
We, The Patients have announced they will host a free medical cannabis education event in London in November to bridge... read more
A study has cast doubt on the widely cited claim that antidepressant drugs such as SSRIs have few withdrawal symptoms,... read more
Kevin Pattah honed his entrepreneurial skills working in his family’s grocery and real estate businesses in West Bloomfield, Michigan, and... read more
Vaporised cannabis containing both THC and CBD has been shown to reduce migraine symptoms for up to 48 hours in... read more
Over the years, 4/20 has evolved from being a celebration of cannabis culture to a day where shoppers can find... read more
The motion calls for an end to discrimination faced by people who use CBPMs and is the first time a... read more
Growth is one of the most thrilling aspects of business — but not all growth is created equal. Expansion without... read more
When Jeremy Berke left Business Insider at the end of 2022, he didn’t necessarily intend on launching his own media... read more
